Article Details
Retrieved on: 2018-03-05 18:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Meditor Group Ltd increased its stake in Celldex Therapeutics (CLDX) by 8.84% based on its latest 2017Q3 regulatory filing with the SEC. Meditor Group Ltd bought 512,700 shares as the company's stock declined 11.75% while stock markets rallied. The institutional investor held 6.31 million shares of ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here